NDAC
This article was originally published in The Tan Sheet
Executive Summary
May 11 meeting on OTC availability of low- and non-sedating antihistamines will be held at Holiday Inn, Two Montgomery Village Ave., Gaithersburg, Md. from 8 a.m. to 5 p.m. (1"The Tan Sheet" March 19, p. 3). For more information contact Sandra Titus or Kimberly Topper at 301-827-7001. Persons wishing to present data at meeting must submit materials by May 2
You may also be interested in...
Antihistamine OTC Switch Petition Slated For NDAC Debate May 11
FDA's decision to bring a citizen petition seeking OTC status of three low- and non-sedating antihistamine drugs before NDAC may be an attempt to apply public pressure on Schering-Plough, Aventis and Pfizer to accelerate any plans they may have to initiate switches on their own.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands